Show simple item record

dc.contributor.authorDickey, Barbara
dc.contributor.authorNormand, Sharon-Lise T.
dc.contributor.authorNorton, Edward C.
dc.contributor.authorAzeni, Hocine
dc.contributor.authorFisher, William H.
dc.date2022-08-11T08:10:23.000
dc.date.accessioned2022-08-23T17:06:53Z
dc.date.available2022-08-23T17:06:53Z
dc.date.issued1998-04-01
dc.date.submitted2011-01-05
dc.identifier.citationClin Drug Investig. 1998;15(4):303-8.
dc.identifier.issn1173-2563 (Linking)
dc.identifier.pmid18370485
dc.identifier.urihttp://hdl.handle.net/20.500.14038/45206
dc.description.abstractIn the USA, mental health expenditures have been rising at a rate that exceeds other medical expenditures. To control these costs, insurance companies and governmental agencies responsible for health benefit plans have turned to managed care companies who review utilisation of services and who negotiate fee reductions with providers. In this study, we examined changes in patterns of care and per person expenditures among Medicaid enrollees with major mental illness. We found that after the introduction of managed care, per person expenditures were reduced by about 25%, accomplished primarily by limiting hospital admissions. We also found that admissions (and the associated costs) were not shifted to the Department of Mental Health, which funds state hospital long-term care for the indigent. Measures of continuity of care were unchanged during the study period. We conclude that managed care met its cost-containment goals without shifting costs to another state agency.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18370485&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.ingentaconnect.com/content/adis/cdi/1998/00000015/00000004/art00006
dc.subjectManaged Care Programs
dc.subjectMental Health Services
dc.subjectCost Control
dc.subjectHealth Expenditures
dc.subjectPhysician's Practice Patterns
dc.subjectHealth Services Research
dc.subjectMental and Social Health
dc.subjectPsychiatric and Mental Health
dc.subjectPsychiatry
dc.subjectPsychiatry and Psychology
dc.titleTreatment of long-term psychiatric disorders in the managed care environment: an observational longitudinal study
dc.typeJournal Article
dc.source.journaltitleClinical drug investigation
dc.source.volume15
dc.source.issue4
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/psych_cmhsr/307
dc.identifier.contextkey1718664
html.description.abstract<p>In the USA, mental health expenditures have been rising at a rate that exceeds other medical expenditures. To control these costs, insurance companies and governmental agencies responsible for health benefit plans have turned to managed care companies who review utilisation of services and who negotiate fee reductions with providers. In this study, we examined changes in patterns of care and per person expenditures among Medicaid enrollees with major mental illness. We found that after the introduction of managed care, per person expenditures were reduced by about 25%, accomplished primarily by limiting hospital admissions. We also found that admissions (and the associated costs) were not shifted to the Department of Mental Health, which funds state hospital long-term care for the indigent. Measures of continuity of care were unchanged during the study period. We conclude that managed care met its cost-containment goals without shifting costs to another state agency.</p>
dc.identifier.submissionpathpsych_cmhsr/307
dc.contributor.departmentDepartment of Psychiatry
dc.source.pages303-8


This item appears in the following Collection(s)

Show simple item record